FDA applicant
Saluda Medical Pty, Ltd.
FDA records 1 decision for Saluda Medical Pty, Ltd. (Atarmon) in 2022: 1 original PMA approval. All are in product code LGW (Stimulator, Spinal-Cord, Totally Implanted For…). No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Saluda Medical Pty, Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2022
2022high 1 (2022) · low 0 (2023)2026
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2022.
Planning a device like Saluda Medical Pty, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report